SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MultiCell Technologies, Inc.
MCET 0.000001000-90.0%Jun 6 1:41 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Tradenride10/9/2004 4:08:22 PM
  Read Replies (1) of 237
 
Re: EAC on RB

immortalmucl, lets keep the pressure on eac. Keep in mind once you start making too much sense he will ignore you. I am surprised he has not ignored you already like dog and me. Remember, he has an agenda. If you look at the last three quarters you will see that cash flow is more instructive because XenoTech is responsible for any costs related to sales. The costs of on going ops have been alleviated due to outsourcing of production, sales and packaging/shipping. This is the result of Jerry's reorganization plan and BTW, general and administrative costs from that reorganization are done. The burn rate has been cut in half if not more and that is why Jerry made the statement in 7/15 10q, "The additional royalties we will now begin to receive from XenoTech may be sufficient to cover our cash requirements for ongoing operations." These are the things eac conveniently avoids because he cannot argue these points. He is very, very selective in his replies and that is why he copies and pastes specific statements from your posts that he can manipulate into a negative outlook for the company. I will post this on SI so he can see I am still making sense.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext